A detailed history of Wallace Advisory Group, LLC transactions in Organon & Co. stock. As of the latest transaction made, Wallace Advisory Group, LLC holds 11,711 shares of OGN stock, worth $214,194. This represents 0.18% of its overall portfolio holdings.

Number of Shares
11,711
Previous 11,711 -0.0%
Holding current value
$214,194
Previous $242 Million -0.0%
% of portfolio
0.18%
Previous 0.17%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 21, 2023

BUY
$23.31 - $28.61 $272,983 - $335,051
11,711 New
11,711 $327 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $4.65B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Wallace Advisory Group, LLC Portfolio

Follow Wallace Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wallace Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wallace Advisory Group, LLC with notifications on news.